10 Stocks Going Wild

5. CRISPR Therapeutics AG (NASDAQ:CRSP)

Crispr Therapeutics rallied for a second day on Wednesday, adding 9.6 percent to close at $60.08 apiece, tracking the rally in the biotechnology sector and the broader market.

During the session, the biotechnology industry rose by 3.58 percent amid a flurry of developments in the sector. Meanwhile, Wall Street’s main indices all finished in the green territory.

Additionally, investors may have begun repositioning portfolios ahead of the release of second-quarter earnings results. Based on its historical reporting dates, CRISPR Therapeutics AG (NASDAQ:CRSP) will announce its financial and operating results in the first week of August.

In the first quarter of the year, CRISPR Therapeutics AG (NASDAQ:CRSP) widened its net loss by 17 percent to $136 million from $116 million previously.

Revenues, however, jumped by 71.6 percent to $865 million from $504 million year-on-year.